Table 1 Comparisons between subjects with and without aspirin therapy
From: Effects of low-dose aspirin in subjects with dyslipidemia
Variables | With aspirin (n = 138) | Without aspirin (n = 64) |
|---|---|---|
Male (%) | 72 (52.3) | 33 (51.7) |
Age (years) | 53.2 ± 8.4 | 51.7 ± 6.9 |
Smoking (%) | 66 (47.8) | 30 (46.9) |
SBP (mmHg) | 135.7 ± 17.4 | 131.3 ± 12.8 |
DBP (mmHg) | 71.4 ± 10.3 | 70.6 ± 11.6 |
HR (bpm) | 75.5 ± 13.2 | 72.6 ± 13.1 |
Waist-Hip ratio | 0.89 ± 0.03 | 0.88 ± 0.05 |
TC (mmol/L) | 5.13 ± 0.24 | 5.11 ± 0.22 |
TG (mmol/L) | 1.54 ± 0.32 | 1.57 ± 0.30 |
LDL (mmol/L) | 3.36 ± 0.41 | 3.40 ± 0.36 |
HDL (mmol/L) | 0.93 ± 0.06 | 0.92 ± 0.06 |
Lp(a) (mg/L) | 238.96 ± 26.45 | 244.35 ± 33.15 |
ApoA1 (mmol/L) | 1.06 ± 0.33 | 1.05 ± 0.29 |
ApoB (mmol/L) | 1.10 ± 0.26 | 1.11 ± 0.30 |
FPG (mmol/L) | 5.3 ± 0.6 | 5.4 ± 0.5 |
HbA1c (%) | 5.9 ± 0.8 | 5.8 ± 0.6 |
Hs-CRP (mg/L) | 10.7 ± 3.5 | 11.4 ± 3.2 |
Hypertension (%) | 36 (26.1) | 18 (28.1) |
Diabetes (%) | 19 (13.8) | 10 (15.6) |
CHD (%) | 25 (18.1)* | 15 (23.4) |
Intracranial hemorrhage (%) | 0 (0) | 0 (0) |
Gastrointestinal bleeding (%) | 5 (3.6)* | 0 (0) |
HP infection (%) | 12 (8.7)* | 3 (4.7) |
Statins (%) | 127 (92.0) | 60 (93.8) |
Anti-hypertension (%) | 27 (19.6) | 11 (17.2) |
Anti-diabetes (%) | 15 (10.9) | 8 (12.5) |